Self-monitoring of blood glucose in type 2 diabetes: Is the debate (finally) ending?

Diabetes Research and Clinical Practice

Volumn 97, Issue 1, 2012, Pages 1-2

  Ceriello, Antonio ^a,b  

^a INSTITUT D INVESTIGACIONS BIOMÈDIQUES AUGUST PI I SUNYER IDIBAPS   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT; GLUCOSE; HEMOGLOBIN A1C; INSULIN;

AGE; BLOOD GLUCOSE MONITORING; BODY MASS; CHRONIC KIDNEY FAILURE; CLINICAL PRACTICE; COMORBIDITY; CONSENSUS DEVELOPMENT; DIABETIC ANGIOPATHY; DIABETIC MACROANGIOPATHY; DIABETIC MICROANGIOPATHY; EDITORIAL; GLYCEMIC CONTROL; HEMOGLOBIN BLOOD LEVEL; HUMAN; MEDICAL DECISION MAKING; METABOLIC REGULATION; NON INSULIN DEPENDENT DIABETES MELLITUS; RANDOMIZED CONTROLLED TRIAL (TOPIC); TREATMENT PLANNING;

BLOOD GLUCOSE; BLOOD GLUCOSE SELF-MONITORING; DIABETES MELLITUS, TYPE 2; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MALE;

EID: 84864100701     PISSN: 01688227     EISSN: 18728227     Source Type: Journal    
DOI: 10.1016/j.diabres.2012.03.013     Document Type: Editorial

References (6)

1. Farmer A.J., Perera R., Ward A., Heneghan C., Oke J., Barnett A.H., et al. Meta-analysis of individual patient data in randomised trials of self monitoring of blood glucose in people with non-insulin treated type 2 diabetes. BMJ 2012, 344(February):e486. 10.1136/bmj.e486.
2. Parkin C.J. Results that matter: structured vs. unstructured self-monitoring of blood glucose in type 2 diabetes. Diabetes Res Clin Pract 2012, 97:6-15.
3. Klonoff D.C., Blonde L., Cembrowski G., Chacra A.R., Charpentier G., Colagiuri S., et al. Consensus report: the current role of self-monitoring of blood glucose in non-insulin-treated type 2 diabetes. J Diabetes Sci Technol 2011, 5:1529-1548.
4. Lalic N., Tankova T., Nourredine M., Parkin C., Schweppe U., Amann-Zalan I. Value and utility of structured self-monitoring of blood glucose in real world clinical practice: findings from a multinational observational study. Diabetes Technol Ther 2012, [Epub ahead of print].
5. Scavini M., Bosi E., Ceriello A., Giorgino F., Porta M., Tiengo A., et al. Prospective, randomized trial on intensive SMBG management added value in non-insulin-treated T2DM patients (PRISMA): a study to determine the effect of a structured SMBG intervention. Acta Diabetol 2011, [Epub ahead of print].
6. Ceriello A., Gallo M., Armentano V., Perriello G., Gentile S., De Micheli A. Personalizing treatment in type 2 diabetes: a self-monitoring of blood glucose inclusive innovative approach. Diabetes Technol Ther 2012, [Epub ahead of print].